You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 272 No. 14, October 12, 1994 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Crossing the Divide From Vaccine Technology to Vaccine Delivery

The Critical Role of Providers

Walter A. Orenstein, MD; Roger H. Bernier, PhD, MPH

JAMA. 1994;272(14):1138-1139.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

On May 14, 1796, Edward Jenner performed the first successful vaccination against smallpox with virus obtained from a woman infected with cowpox. In the almost 200 years since that sentinel event, smallpox has been eradicated and polio has been eliminated from the Americas. Sophisticated biotechnology has brought us hepatitis B vaccine, the first licensed vaccine developed using recombinant DNA techniques. New technology has permitted linkage of Haemophilus influenzae type b capsular polysaccharide to protein carriers to improve the immune response of infants, and H influenzae type b invasive disease has been reduced by more than 95% in the 5 years since introduction of the first conjugate vaccines.1 As reported by Granoff et al2 in this issue of THE JOURNAL, research continues into improving the already excellent immune response to these conjugate vaccines.

While much more remains to be done in developing new and improved vaccines, the system of . . . [Full Text PDF of this Article]


Author Affiliations

From the National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga.


Footnotes

Reprint requests to National Immunization Program, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop E-05, Atlanta, GA 30333 (Dr Orenstein).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.